These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7871196)

  • 1. [Clinical probes using tumor necrosis factor in treatment of neoplastic diseases].
    Szczepanik A; Tabor J; Siedlar M
    Przegl Lek; 1994; 51(11):497-500. PubMed ID: 7871196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor necrosis factor-alpha--phase I and phase II clinical trials].
    Chciałowski A; Targowski T; Bajera I; Jahnz-Rózyk K
    Pol Merkur Lekarski; 1997 Jun; 2(12):396-9. PubMed ID: 9424335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recombinant human tumor necrosis factor alpha (TNF): preclinical studies and results of early clinical trials].
    Płuzańska A
    Acta Haematol Pol; 1994; 25(2 Suppl 1):148-54. PubMed ID: 8067200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor necrosis factor-alpha--biological and immunologic properties].
    Chciałowski A; Targowski T; Bajera I; Jahnz-Rózyk K
    Pol Merkur Lekarski; 1997 Jun; 2(12):392-5. PubMed ID: 9424334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional immunotherapy for liver metastases and the potential of TNF alpha in hepatic perfusion from laboratory to the clinic.
    Eggermont AM
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1371-8. PubMed ID: 8854756
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of intravenous treatment with tumor necrosis factor alpha in patients with advanced cancer--phase I clinical trials].
    Muc M; Baranowski M
    Przegl Lek; 1995; 52(10):496-8. PubMed ID: 8834840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor for the treatment of malignancies.
    Hieber U; Heim ME
    Oncology; 1994; 51(2):142-53. PubMed ID: 8196898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor: clinical relevance.
    Jones AL; Selby P
    Cancer Surv; 1989; 8(4):817-36. PubMed ID: 2701729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
    Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII).
    Wu PC; Alexander HR; Huang J; Hwu P; Gnant M; Berger AC; Turner E; Wilson O; Libutti SK
    Cancer Res; 1999 Jan; 59(1):205-12. PubMed ID: 9892208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
    Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC
    Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor targeting with biotinylated tumor necrosis factor alpha: structure-activity relationships and mechanism of action on avidin pretargeted tumor cells.
    Corti A; Gasparri A; Sacchi A; Curnis F; Sangregorio R; Colombo B; Siccardi AG; Magni F
    Cancer Res; 1998 Sep; 58(17):3866-72. PubMed ID: 9731496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G; Gekeler V; Leja A; Beckers T; Boehm M
    Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease.
    Robins HI; D'Oleire F; Grosen E; Spriggs D
    Anticancer Res; 1997; 17(4B):2891-4. PubMed ID: 9329556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.
    Yasui H; Adachi M; Imai K
    Cancer; 2003 Mar; 97(6):1412-20. PubMed ID: 12627504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
    Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
    Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
    van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
    Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.